We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanoparticle-Coated T-cells Destroy Tumors in Mouse Model

By LabMedica International staff writers
Posted on 07 Sep 2010
Print article
A team of immunologists working with a mouse model has shown that it is possible to augment the activity of therapeutic immune cells by coating their surfaces with adjuvant drug–loaded nanoparticles.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) designed drug-carrying nanoparticles based on liposomes that were capable of seeking out and binding to sulfur-containing molecules on immune T-cell surface membranes. To achieve maximal immune stimulation, the nanoparticles were loaded with interleukins 15 and 21 (IL-15 and IL-21).

A paper published in the August 15, 2010, online edition of the journal Nature Medicine described a study in which the investigators injected packets comprising about 100 nanoparticle-coated T-cells into mice with lung and bone marrow tumors. Upon reaching the site of the tumors, the nanoparticles gradually degraded and released their load of drugs over a seven-day period.

The drugs attached to receptors on the surface of T-cells in the area and stimulated them to grow and divide. These activated cells destroyed the tumors within 16 days, and the treated mice survived until the end of the 100-day experiment. Mice that received no treatment died within 25 days, and mice that received either T-cells alone or T-cells with injections of interleukins died within 75 days.

"There are lots of people studying nanoparticles for drug delivery, especially in cancer therapy, but the vast majority of nanoparticles injected intravenously go into the liver or the spleen. Less than 5% percent reach the tumor,” said senior author Dr. Darrell J. Irvine, associate professor of materials science and engineering at the Massachusetts Institute of Technology. "What we're looking for is the extra nudge that could take immune-cell therapy from working in a subset of people to working in nearly all patients, and to take us closer to cures of disease rather than slowing progression.”

Related Links:

Massachusetts Institute of Technology


Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.